Inventors: Sajeli Begum

The study focuses on synthesizing novel coumarin-based lignans designed to target pro-inflammatory cytokines for treating chronic kidney disease (CKD). Coumarin-based lignans are compounds with potential anti-inflammatory properties. The research involves developing these novel lignans to specifically inhibit cytokines that contribute to inflammation and progression of CKD.